A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Pilot Study to Evaluate Effects of Emixustat Hydrochloride on Aqueous Humor Biomarkers Associated With Proliferative Diabetic Retinopathy
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Emixustat (Primary)
- Indications Diabetic retinopathy
- Focus Biomarker; Pharmacodynamics
- Sponsors Acucela
- 17 Jan 2018 Status changed from recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 20 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Dec 2017.